{"prompt": "['2016N293064_0', 'CONFIDENTIAL', '2018N394263_00', '205864', '5. PK sample may not be required for participants known to be receiving placebo or non-GSK comparator', 'treatments.) Record the date/time of the PK blood sample draw and the date/time of the last dose of study', 'treatment prior to PK blood sample draw on the CRF. If the date or time of the last dose is unclear, provide the', \"participant's best approximation. If the date/time of the last dose cannot be approximated OR a PK sample cannot\", 'be collected in the time period indicated above, do not obtain a PK sample. Instructions for sample handling and', 'shipping are in the SRM.', 'Phase II liver chemistry increased monitoring criteria with continued therapy', 'Liver Chemistry Increased Monitoring Criteria - Liver Monitoring Event', 'Criteria', 'Actions', 'Notify the GSK medical monitor within 24 hours of', 'ALT >3xULN and <5xULN and bilirubin', 'learning of the abnormality to discuss participant', '<2xULN, without symptoms believed to', 'safety.', 'be related to liver injury or', 'Participant can continue study treatment', 'hypersensitivity, and who can be', 'monitored weekly for 4 weeks', 'Participant must return weekly for repeat liver', 'chemistries (ALT, AST, alkaline phosphatase,', 'bilirubin) until they resolve, stabilise or return to', 'within baseline', 'If at any time participant meets the liver chemistry', 'stopping criteria, proceed as described above', 'If, after 4 weeks of monitoring, ALT <3xULN and', 'bilirubin <2xULN, monitor participants twice monthly', 'until liver chemistries normalize or return to within', 'baseline.', 'Reference', 'James LP, Letzig L, Simpson PM, Capparelli E, Roberts DW, Hinson JA, Davern TJ, Lee', 'WM. Pharmacokinetics of Acetaminophen-Adduct in Adults with Acetaminophen', 'Overdose and Acute Liver Failure. Drug Metab Dispos 2009; 37:1779-1784.', '78']['2016N293064_0', 'CONFIDENTIAL', '2018N394263_00', '205864', '12.8.', 'Appendix 8: Medical Device Incidents: Definition and', 'Procedures for Recording, Evaluating, Follow-up, and', 'Reporting', 'Definition and Documentation of Medical Device Incidents', 'Definitions of a Medical Device Incident', 'The detection and documentation procedures described in this protocol apply to all GSK', 'medical devices provided for use in the study (see Section 7.1.1) for the list of GSK', 'medical devices).', 'Medical Device Incident Definition', 'A medical device incident is any malfunction or deterioration in the characteristics', 'and/or performance of a device as well as any inadequacy in the labeling or the', 'instructions for use which, directly or indirectly, might lead to or might have led to', 'the death of a participant/user/other person or to a serious deterioration in his/her', 'state of health.', 'Not all incidents lead to death or serious deterioration in health. The nonoccurrence', 'of such a result might have been due to other fortunate circumstances or to the', 'intervention of health care personnel.', 'It is sufficient that:', 'An incident associated with a device happened and', 'The incident was such that, if it occurred again, might lead to death or a serious', 'deterioration in health.', 'A serious deterioration in state of health can include any of the following:', 'Life-threatening illness', 'Permanent impairment of body function or permanent damage to body structure', 'Condition necessitating medical or surgical intervention to prevent one of the', 'above', 'Fetal distress, fetal death, or any congenital abnormality or birth defects', '79']['2016N293064_0', 'CONFIDENTIAL', '2018N394263_00', '205864', 'Examples of incidents', 'A participant, user, caregiver, or healthcare professional is injured as a result of a', 'medical device failure or its misuse.', \"A participant's study treatment is interrupted or compromised by a medical device\", 'failure.', 'A misdiagnosis due to medical device failure leads to inappropriate treatment.', \"A participant's health deteriorates due to medical device failure.\", 'Documenting Medical Device Incidents', 'Medical Device Incident Documenting', 'Any medical device incident occurring during the study will be documented in the', \"participant's medical records, in accordance with the investigator's normal clinical\", 'practice, and on the appropriate form.', 'For incidents fulfilling the definition of an AE or an SAE, the appropriate AE/SAE', 'CRF page will be completed as described in Appendix 4.', 'The form will be completed as thoroughly as possible and signed by the investigator', 'before transmittal to the GSK.', 'It is very important that the investigator provides his/her assessment of causality', '(relationship to the medical device provided by GSK) at the time of the initial report', 'and describes any corrective or remedial actions taken to prevent recurrence of the', 'incident.', 'A remedial action is any action other than routine maintenance or servicing of a', 'medical device where such action is necessary to prevent recurrence of an incident.', 'This includes any amendment to the device design to prevent recurrence.', '80']\n\n###\n\n", "completion": "END"}